Effect of the acute administration of haloperidol and pimozide on plasma GH levels in acromegaly

Acta Endocrinol (Copenh). 1979 Aug;91(4):609-15. doi: 10.1530/acta.0.0910609.

Abstract

In 11 untreated acromegalic patients the plasma GH levels were determined after the acute administration of bromocriptine, haloperidol, pimozide (only in 8 patients) and of placebo. A 50% or more suppression of the basal GH levels was arbitrarily defined as a positive response to bromocriptine. Five patients displayed a negative response to bromocriptine. Of these, 4 responded to both antidopaminergic drugs. We conclude that the acute administration of antidopaminergic drugs reduces the GH secretion in some bromocriptine-insensitive acromegalic patients. Therapeutical implications will require further studies.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Acromegaly / blood
  • Acromegaly / drug therapy*
  • Administration, Oral
  • Adult
  • Bromocriptine / therapeutic use
  • Drug Evaluation
  • Female
  • Growth Hormone / blood*
  • Haloperidol / administration & dosage
  • Haloperidol / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pimozide / administration & dosage
  • Pimozide / therapeutic use*
  • Placebos
  • Thyrotropin-Releasing Hormone / therapeutic use

Substances

  • Placebos
  • Pimozide
  • Bromocriptine
  • Thyrotropin-Releasing Hormone
  • Growth Hormone
  • Haloperidol